Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.56 |
| ▸ | CA9 | Q16790 | 5/20 | 0.56 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | MMP1 | P03956 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP3 | P08254 | 1/20 | 0.52 |
| ▸ | MMP8 | P22894 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8059769 | 0.95 | CA12 (0.52) | CA12CA9CA1MMP1MMP2 | |
| SCHEMBL7380412 | 0.92 | CA12 (0.48) | CA12CA9CA1MMP1MMP2 | |
| SCHEMBL11883049 | 0.90 | CA12 (0.50) | CA12CA9CA1MMP1MMP2 | |
| SCHEMBL11589764 | 0.90 | CA12 (0.50) | CA12CA9CA1MMP1MMP2 | |
| SCHEMBL14244845 | 0.90 | CA12 (0.50) | CA12CA9CA1MMP1MMP2 | |
| SCHEMBL1920702 | 0.90 | CA12 (0.50) | CA12CA9CA1MMP1MMP2 | |
| SCHEMBL14245075 | 0.90 | CA12 (0.50) | CA12CA9CA1MMP1MMP2 | |
| SCHEMBL8681098 | 0.90 | CA12 (0.50) | CA12CA9CA1MMP1MMP2 | |
| SCHEMBL8627810 | 0.90 | CA12 (0.50) | CA12CA9CA1MMP1MMP2 | |
| SCHEMBL1920829 | 0.90 | CA12 (0.50) | CA12CA9CA1MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119351137-B | Crude oil desalting agent and preparation method thereof | 万达集团股份有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119351137-A | Crude oil desalting agent and preparation method thereof | 万达集团股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119285506-A | Tetrabutyl urea production process capable of reducing waste water amount | 重庆长风化学工业有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-114478323-A | Method and system for continuously preparing tetrabutyl urea by using phosgene | 青岛科技大学 | 2022-05-13 | — | — | CN | claimed |
| CN-104114531-A | Process for preparation of n,n-di substituted carboxamides | DIRECTOR GENERAL DEFENCE RES AND DEV ORGANISATION | 2014-10-22 | — | — | CN | claimed |
| EP-4747247-A1 | NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | Apogee Pharmaceuticals, Inc. (CA) | 2026-05-27 | — | — | EP | disclosed |
| US-12410137-B2 | Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-09-09 | — | — | US | disclosed |
| US-20250129027-A1 | FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-04-24 | — | — | US | disclosed |
| EP-3157523-B1 | MULTIFUNCTIONAL AMINOQUINOLINE THERAPEUTIC AGENTS | LOHOCLA RES CORPORATION (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-119351137-B | Crude oil desalting agent and preparation method thereof | 万达集团股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119504508-A | Synchronous preparation method of tetrabutyl urea and phenol | 昌德新材科技股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119351137-A | Crude oil desalting agent and preparation method thereof | 万达集团股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| US-3989710-A | POSTEMERGENCE HERBICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
| US-3966801-A | ANTIINFLAMMATORY AGENTS | WILLIAM H. RORER, INC. (US) | 1976-06-29 | — | — | US | disclosed |
| US-3954567-A | Evaporating solutions which contain phosgene in a vacuum liquid ring pump | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
| US-3953546-A | PESTICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-04-27 | — | — | US | disclosed |
| US-3951976-A | 1-Thiadiazoly-6-carbamoyloxytetrahydropyrimidinones | VELSICOL CHEMICAL CORPORATION (US) | 1976-04-20 | — | — | US | disclosed |
| US-3941821-A | ANTIINFLAMMATORY, ANALGESICS, ANTIPYRETICS | WILLIAM H. RORER, INC. (US) | 1976-03-02 | — | — | US | disclosed |
| US-3941783-A | Process for the production of N,N-disubstituted carboxylic amides | ESZAKMAGYARORSZAGI VEGYIMUVEK (HU) | 1976-03-02 | — | — | US | disclosed |
| US-3931269-A | ANTIINFLAMMATORY | WILLIAM H. RORER, INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129027-A1 | FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | FAAH, FAAH2, MGLL | CA12 2759/4885CA9 1498/4885CA1 1241/4885 |
| US-12410137-B2 | Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof | FAAH, FAAH2, MGLL | CA12 2759/4885CA9 1498/4885CA1 1241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.